Marijuana Opponents Attack Government Analysis Behind Rescheduling Recommendation On Second Day Of DEA Hearing
Lawyers opposing marijuana rescheduling presented arguments during the second day of a DEA hearing on the Trump administration's cannabis rescheduling proposal, focusing on challenging a government witness regarding recently adopted changes to the analysis used to assess medical value. The hearing is part of the federal rescheduling review process that could have significant implications for cannabis policy nationally.
Filed under Court Ruling in THC Minnesota's coverage of Minnesota's cannabis and hemp market.
Mentioned
Source Attribution
This summary was compiled from information published by Marijuana Moment. All facts and statements reflect the original source material. For complete details, refer to the original publication.
View Original Source →Related Updates
Marijuana Moment Asks DEA Judge To Allow Livestreaming Of Rescheduling Hearing For Transparent Public Access
Trump Is Being Sued For Rescheduling Marijuana By Doctors And A Pharmaceutical Company Who Are ‘Aggrieved’ By The Move
DEA Defends Stance That Synthetic Cannabis Compound HHC Is Federally Banned In Response To Industry Lawsuits
Hemp Companies Sue DEA, Challenging Agency’s Claim That Synthetic Cannabis Compound HHC Is Federally Banned
Marijuana Rescheduling Appeal Process ‘Remains Pending’ Despite Trump’s Executive Order, DEA Says In New Filing
DOJ rethinks cannabis & gun prosecutions (Newsletter: May 1, 2026)
Stay current on Minnesota cannabis
Browse more court ruling updates, the full news feed, or the Minnesota cannabis timeline. Compare products across licensed dispensaries and read our consumer guides.